Background: While limited data suggest that the fecal microbiota in healthy people is
evaluated with the low-error amplicon sequencing (LEA-Seq) technique were stable in 37 healthy adults sampled 2 to 13 times up to 296 wk apart. 8 By contrast, the fecal microbiota profile varied considerably over 6 and 15 mo in two healthy people. 9 Among 43 healthy individuals, single nucleotide polymorphism variations, but not the bacterial species in 88 fecal metagenomes, were stable over 37-378 d. 10 Longitudinal sampling in 85 healthy adults at weekly intervals over 3 mo disclosed considerable temporal variability. 11 Similar to the composition of the individual microbiome, this too is personalized. Data from the Human
Microbiome Project indicate that only approximately 30% of samples, as defined by taxa abundance-based metagenomic 'codes' and a measure of beta diversity, were stable for up to 450 d. 6 Conceivably, temporal variations in the microbiota profile may be related not only to the disease state but also to alterations in diet, drugs, colonic transit, body mass index (BMI), and antibiotic use. 3, [12] [13] [14] [15] Hence, longitudinal assessments may be useful to more rigorously characterize fecal microbiota profiles in disease states. 16 In IBS, particularly in diarrhea-predominant IBS, the fecal microbiota evaluated with older methods, not 16S rRNA techniques, was unstable over time. [17] [18] [19] Therefore, it is necessary to evaluate the intraindividual stability of the fecal microbiota with 16S
rRNA techniques in IBS and chronic constipation. Indeed, because
there is an association between stool consistency and the composition of microbiota, 20 it is conceivable that alterations in the fecal microbiota at least partly explain the temporal fluctuation in symptoms, most frequently from constipation-or diarrhea-predominant IBS to mixed type IBS or vice versa. 21 In view of this, the objectives of this study were to (i) compare the intraindividual variability in human fecal microbiota over two samples taken 1 wk apart, in healthy people and constipated patients, and separately, in people with normal or slow colonic transit and (ii) assess the reproducibility of the association between fecal microbiota and diet and physiological parameters (eg, colonic transit and breath methane production). Our hypotheses were that (i) assessments of fecal microbiota in healthy people, patients with constipation, normal, and slow colonic transit are highly reproducible within individuals; (ii) the intraindividual variability of fecal microbiota in patients with constipation, and separately, with normal or slow colonic transit is not significantly different to that in healthy people; and (iii) the associations between the fecal microbiota and physiologic parameters (eg, breath methane production, and colonic transit) are also reproducible. 
| MATERIALS AND METHODS

| Study design and participants
| Assessment of dietary intake
Before starting study procedures, a registered dietitian advised participants to maintain a stable diet for 1 wk before and throughout the study; and to follow a low fiber diet and avoid dairy products, high fructose corn syrup, fruits, fruit juices, honey, "sugar-free" candies, gums or products containing sorbitol, and live or active cultured-containing foods for 24 h prior to the lactulose breath test. Participants were instructed to complete a food record for 3 d before the stool collection.
Nutrition analysis of the food records was performed using the ESHA Food Processor software (Version 10.14, ESHA Research, Salem, OR, USA). All study participants were instructed to not use pre or probiotics during the study. Only one patient was on a probiotic of doubtful efficacy that was discontinued 1 wk before the study. 
| Scintigraphic assessment of colonic transit
| Stool collection
Standardized instructions and stool kits were provided to patients for collecting stool samples, which were frozen and stored in a −80°C
freezer. The first stool sample was collected without a laxative in all
Key points
• The intraindividual reproducibility of fecal microbiota in constipation is incompletely understood.
• The agreement between two fecal samples for all measures of alpha and beta diversity in healthy people and patients with chronic constipation was moderate or strong.
• For most purposes, evaluating the fecal microbiota in a single stool sample is generally sufficient in adequately powered studies.
participants, with the exception of one patient who required an enema and another patient who required a laxative before providing the first sample. The second stool sample was collected within 7 d of the first sample; magnesium hydroxide (60 mL) and bisacodyl (5 mg) were administered to all participants the night before sample collection. stitched, aligned, and classified using a custom pipeline (TORNADO v2.0). 27 Briefly, low base quality reads were either trimmed or discarded, 28 and these reads were not classified as a bacteria kingdom 29 or matched to the bacteria 16S rRNA secondary structure. 30 To evaluate the microbial diversity and abundance, UPARSE was used for Operational Taxonomical Units (OTU) clustering, 31 and FastTree was used for phylogeny. 32 The 16S data were clustered into OTUs at 97% sequence similarity, and the taxonomy was assigned using the Ribosomal Database Project classifier and Greengenes database (v13.5)
| Sequencing and analytical methods
| Statistical analysis
The temporal stability of the stool microbiome over the two visits 
| RESULTS
| Patient characteristics
The demographic and clinical characteristics of the study participants have been detailed previously. 3 Salient findings are as follows (Table 1) . Of the 25 patients, 13 had symptoms of functional
constipation, six had IBS-C, and six had mixed IBS, predominantly constipation, by Rome III criteria. The constipated patients were older (48±15 vs 39±10 y, P=.02) than healthy participants but had a similar BMI. The total daily caloric intake was less (P=.005) in constipated (1265±350 kcal) than healthy participants (1597±402 kcal).
Compared to patients, healthy participants also consumed more carbohydrate (P=.054), protein (P=.002), fat (P=.03), and fiber (P=.01) when expressed as an absolute amount, but not as a proportion of the total calorie intake. Gastric emptying at 2 h, but not at 4 h, was lower (P<.01) in constipated patients than in healthy participants. There was no difference in small intestinal transit between the two groups.
Fourteen patients (nine with functional constipation, three with IBS-C, and two with mixed IBS) but only two controls (P<.005), had delayed colonic transit. Six healthy participants but no patients had rapid colonic transit. Colonic transit (GC24) was directly correlated with total calorie intake (r=.31, P<.05) and total fiber intake (r=.36, P<.05), and inversely correlated with age (r=−.32, P<.05).
| Reproducibility of overall composition of fecal microbiota
With some exceptions, the ICCs for most measures of alpha and beta diversity were high and similar in healthy participants and constipated patients ( Table 2 , Figure 1 ). The alpha diversity measures the species In contrast to alpha diversity, the beta diversity reflects the diversity between samples. The ICC for the Bray-Curtis dissimilarity, which measures the species overlap between two populations, and for the unweighted UniFrac distance, which measures the shared OTU membership on a phylogenetic tree, was high in all cohorts (Table 2) 
| Reproducibility of taxonomic composition of fecal microbiota
The ICCs for taxonomic abundances were moderate to high. At the phylum level, the ICC for Proteobacteria was lower (P=.01) in healthy participants than in constipated patients. By contrast, the ICCs for Bacteroidetes and Firmicutes were not significantly different between constipated patients and healthy participants, and between participants with normal and slow colonic transit. The taxa which accounted for these lower ICCs at the genus level were also identified ( Table 3) .
The OTU-level abundance profile in the first and second samples was significantly correlated in the entire cohort as well as in subgroups (ie, healthy participants, constipated patients, and participants with normal or slow colonic transit) (Figure 2 ).
We next tested for the effect of laxative treatment on the microbiota composition. Based on PERMANOVA, we did observe a significant effect (P=.05, unweighted UniFrac), indicating that the temporal variance could be partially explained by the laxative treatment. Paired
Wilcoxon tests suggested that at the genus level, Oscillospira was more abundant in the first sample (before laxative treatment), while
Phascolarctobacterium, Veillonella, and Erwinia were more abundant in the second sample (after laxative treatment). These differences were significant before (P<.05) but not after adjusting for multiple testing using FDR control.
| Reproducibility of associations between fecal microbiota and other variables
We next studied the reproducibility of the associations we observed in our previous study using the first sample. 3 We focused on the univariate association tests based on PERMANOVA. With a few exceptions, univariate associations between the fecal microbiota and other parameters were comparable in the first and second stool samples (Table 4 ). The fecal microbiota profile was associated with total calorie intake in the first but not in the second stool sample.
| Sample size requirements
The sample size required to identify differences between fecal microbiota measurements in two groups with a two-sample t test was first estimated assuming no measurement error (ICC=1.0). At 80% power and an alpha level of 0.05, 25, 50, and 100 individuals per group are required to detect hypothetically defined large, intermediate, and small differences (ie, effect sizes) between groups.
When the ICC for the reproducibility of microbiota parameters is incorporated into the sample size assessment, a greater sample size is required, as the ICC declines ( Figure 3 
| DISCUSSION
In this study, we used ICC to quantify the temporal stability of the stool microbiota based on several microbiota measurements. Besides the ICC measure, other measures that define the temporal variation are also possible. For example, Jalanka-Tuovinen et al. used the coefficient of variation (CoV) to study the temporal stability of the core gut microbial taxa in healthy subjects. 34 The reason we chose the ICC measure over other measures is that ICC is directly related to statistical power, a key issue in the study design. Similar approaches have also been used to study the reproducibility and stability of various fecal sampling methods. [35] [36] [37] [38] [39] Overall, the agreement between two fecal samples for all measures of alpha and beta diversity in healthy people and patients with chronic constipation was moderate or strong. The ICC for number of observed OTUs, which reflect the richness of microbiota, indicated strong agreement. For the Shannon index, which reflects the richness and evenness of fecal microbiota, the agreement between two stool samples was moderate. Similarly, for most measures of beta diversity, the ICCs suggested moderate or strong agreement. Extending previous studies, 7 these observations suggest that for most diversity indices of microbiota composition, a single sample is cost-effective, not only in healthy people but also in constipated patients. However, if the sample size is the major constraint, statistical power could be improved moderately by using several technical replicates. The study also suggested that the composition of fecal microbiota was affected by a laxative.
For some measures of β diversity, ie, the unweighted UniFrac which reflects the presence or absence rather than their abundance in
OTUs, and the Bray-Curtis metric, which attaches an equal weight to all OTUs, the agreement was moderate or strong in all cohorts, includ- reproducibility of the phyla Bacteroidetes and Firmicutes was also lower in patients with normal colonic transit. These observations are consistent with the observation that bowel cleansing with a purgative prior to colonoscopy reduced the abundance of taxa belonging to Bacteroidetes and Firmicutes but not the overall diversity of microbiota. 40 At the genus level, variations in Bacteroides, Lactococcus, and Streptococcus explained the low ICC in participants with normal colonic transit. Conceivably, this poor reproducibility may be partly explained by the effects of laxatives on colonic transit and stool consistency, which, to speculate, may be more pronounced in people with normal compared to slow colonic transit. The fecal microbiota, stool consistency, and colonic transit are known to be univariately associated with each other. Alterations in colonic transit affect stool consistency.
41,42
Stool consistency is associated with several measures of microbiota composition, ie, species richness, enterotypes, and taxonomic composition. 43 Indeed, in a study of 3948 people, stool consistency had the largest effect size on the variation of fecal microbiota. 44 Polyethylene glycol significantly increased the relative abundance of Bacteroides in ex-germ free mice colonized with human fecal microbiota. 45 The univariate associations between the fecal microbiota and other variables were mostly comparable for the first and second stool samples. This provides further evidence for the intraindividual reproducibility of fecal microbiota and also supports the association between fecal microbiota and colonic transit as well as with breath methane production. 3 However, minor differences were observed, which can again be explained by stochastic fluctuation related to a small sample size. However, alternative explanations are also possible. For example, in contrast to the first stool sample, total calorie intake was not significantly associated with the unweighted UniFrac distance, perhaps because the caloric intake was recorded for 3 d before the first stool sample and not thereafter. Acute changes in caloric intake are known to affect the stool microbiota. 14, 46 These data will be useful for selecting the sample size in future studies. 16, 47 The sample size depends on the effect size of the proposed intervention of disease state and the intrasubject variability. 47 For a conservative ICC of approximately 0.5, which is lower than the observed ICC for most parameters in this study, the ideal sample size required to detect a given effect size will be approximately twice of that required for a perfect ICC (ICC=1.0). However, constrained by the absence of a standardized approach to report effect sizes or unknown effect sizes, pilot studies may often be required to estimate effect size. 16 These measurements were obtained using state-of-the-art techniques from a carefully characterized cohort of healthy participants and constipated patients. However, the two stool samples were collected at 7-d intervals. Additional studies are necessary to ascertain if the fecal microbiota is stable over longer time periods, particularly as bowel symptoms may change over time, most frequently from constipation-or diarrhea-predominant IBS to mixed type or vice versa. 21 Similar to a previous study, 48 dietary caloric intake was lower in constipated than healthy participants. However, the reported average daily caloric intake in constipated participants was 1265 Kcal. We cannot exclude the possibility that this 3-d dietary assessment period was not representative of their regular caloric intake.
In conclusion, measurements of fecal microbial diversity are mostly 
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